Loading…
Postoperative follow-up of patients with early breast cancer: reappraisal of serum tumor markers
The purpose of this study was to determine the most appropriate tests and procedures to detect disease progression effectively during the postoperative follow-up of patients with early breast cancer. We reevaluated our current surveillance protocol which involves the intensive follow-up of 643 patie...
Saved in:
Published in: | Surgery today (Tokyo, Japan) Japan), 2002, Vol.32 (1), p.13-18 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c348t-5885b3e6956c7035e43e37ad6c00110080f04bab4a57b30b3707c6d5840ac4893 |
---|---|
cites | |
container_end_page | 18 |
container_issue | 1 |
container_start_page | 13 |
container_title | Surgery today (Tokyo, Japan) |
container_volume | 32 |
creator | Anan, Keisei Mitsuyama, Shoshu Tamae, Keiyoshi Suehara, Nobuhiro Nishihara, Kazuyoshi Ogawa, Yoshiaki Iwashita, Toshimitsu Abe, Yuji Ihara, Takaaki Nakahara, Shosaku Katsumoto, Fujio Toyoshima, Satoshi |
description | The purpose of this study was to determine the most appropriate tests and procedures to detect disease progression effectively during the postoperative follow-up of patients with early breast cancer. We reevaluated our current surveillance protocol which involves the intensive follow-up of 643 patients with stage I disease. With the exception of one case of bone metastasis, all cases of recurrence (97%) were suspected from abnormal results detected during surveillance involving physical examination, serial determination of tumor markers, and chest roentgenography. Among 15 patients with asymptomatic distant metastasis, disease recurrence was suspected in 12 (80%) because of increased levels of serum tumor markers. No disease recurrence was detected by routine complete blood counts or automated chemistry studies alone. Our experience indicates that an effective follow-up regimen for patients with early breast cancer may include careful history-taking, physical examination, and the determination of serum tumor markers every 3-6 months for the first 3 years, then less frequently thereafter, and chest roentgenography every 6 months for 5 years, in addition to annual mammography. Serial determination of the tumor markers tumor polypeptide antigen, NCC-ST-439, and either carcinoembryonic antigen or carbohydrate antigen 15-3, seems to be of value for the selection of patients who should undergo radiologic exploration. The health benefits and cost-effectiveness of a follow-up focused on the measurement of serum tumor markers need to be evaluated in large prospective randomized trials. |
doi_str_mv | 10.1007/s595-002-8106-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71486532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71486532</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-5885b3e6956c7035e43e37ad6c00110080f04bab4a57b30b3707c6d5840ac4893</originalsourceid><addsrcrecordid>eNpFkE1PwzAMhiMEYmNw5oZy4hbmNEmbckMTX9IkOMA5pJkrCu1SkpRp_55Om8TJsvW8lv0QcsnhhgMU86hKxQAypjnkTB2RKZciZ5nm4phMoZSc8azkE3IW49fISQ1wSiac64Jrzqfk49XH5HsMNjW_SGvftn7Dhp76mvbjDNcp0k2TPina0G5pFdDGRJ1dOwy3dOz6Ptgm2naXiBiGjqah84F2NnxjiOfkpLZtxItDnZH3h_u3xRNbvjw-L-6WzAmpE1Naq0pgXqrcFSAUSoGisKvcAfDxVQ01yMpW0qqiElCJAgqXr5SWYJ3UpZiR6_3ePvifAWMyXRMdtq1dox-iKbjUuRLZCM73oAs-xoC16UMzHrs1HMxOqtlJNaMss5Nq1Ji4Oqweqg5X__zBovgDRhRylQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71486532</pqid></control><display><type>article</type><title>Postoperative follow-up of patients with early breast cancer: reappraisal of serum tumor markers</title><source>Springer Nature</source><creator>Anan, Keisei ; Mitsuyama, Shoshu ; Tamae, Keiyoshi ; Suehara, Nobuhiro ; Nishihara, Kazuyoshi ; Ogawa, Yoshiaki ; Iwashita, Toshimitsu ; Abe, Yuji ; Ihara, Takaaki ; Nakahara, Shosaku ; Katsumoto, Fujio ; Toyoshima, Satoshi</creator><creatorcontrib>Anan, Keisei ; Mitsuyama, Shoshu ; Tamae, Keiyoshi ; Suehara, Nobuhiro ; Nishihara, Kazuyoshi ; Ogawa, Yoshiaki ; Iwashita, Toshimitsu ; Abe, Yuji ; Ihara, Takaaki ; Nakahara, Shosaku ; Katsumoto, Fujio ; Toyoshima, Satoshi</creatorcontrib><description>The purpose of this study was to determine the most appropriate tests and procedures to detect disease progression effectively during the postoperative follow-up of patients with early breast cancer. We reevaluated our current surveillance protocol which involves the intensive follow-up of 643 patients with stage I disease. With the exception of one case of bone metastasis, all cases of recurrence (97%) were suspected from abnormal results detected during surveillance involving physical examination, serial determination of tumor markers, and chest roentgenography. Among 15 patients with asymptomatic distant metastasis, disease recurrence was suspected in 12 (80%) because of increased levels of serum tumor markers. No disease recurrence was detected by routine complete blood counts or automated chemistry studies alone. Our experience indicates that an effective follow-up regimen for patients with early breast cancer may include careful history-taking, physical examination, and the determination of serum tumor markers every 3-6 months for the first 3 years, then less frequently thereafter, and chest roentgenography every 6 months for 5 years, in addition to annual mammography. Serial determination of the tumor markers tumor polypeptide antigen, NCC-ST-439, and either carcinoembryonic antigen or carbohydrate antigen 15-3, seems to be of value for the selection of patients who should undergo radiologic exploration. The health benefits and cost-effectiveness of a follow-up focused on the measurement of serum tumor markers need to be evaluated in large prospective randomized trials.</description><identifier>ISSN: 0941-1291</identifier><identifier>EISSN: 1436-2813</identifier><identifier>DOI: 10.1007/s595-002-8106-5</identifier><identifier>PMID: 11871811</identifier><language>eng</language><publisher>Japan</publisher><subject>Adult ; Aged ; Biomarkers, Tumor - blood ; Breast Neoplasms - blood ; Breast Neoplasms - epidemiology ; Breast Neoplasms - surgery ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local - diagnosis ; Physical Examination ; Postoperative Period ; Predictive Value of Tests ; Registries - statistics & numerical data ; Sensitivity and Specificity ; Time Factors</subject><ispartof>Surgery today (Tokyo, Japan), 2002, Vol.32 (1), p.13-18</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c348t-5885b3e6956c7035e43e37ad6c00110080f04bab4a57b30b3707c6d5840ac4893</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11871811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anan, Keisei</creatorcontrib><creatorcontrib>Mitsuyama, Shoshu</creatorcontrib><creatorcontrib>Tamae, Keiyoshi</creatorcontrib><creatorcontrib>Suehara, Nobuhiro</creatorcontrib><creatorcontrib>Nishihara, Kazuyoshi</creatorcontrib><creatorcontrib>Ogawa, Yoshiaki</creatorcontrib><creatorcontrib>Iwashita, Toshimitsu</creatorcontrib><creatorcontrib>Abe, Yuji</creatorcontrib><creatorcontrib>Ihara, Takaaki</creatorcontrib><creatorcontrib>Nakahara, Shosaku</creatorcontrib><creatorcontrib>Katsumoto, Fujio</creatorcontrib><creatorcontrib>Toyoshima, Satoshi</creatorcontrib><title>Postoperative follow-up of patients with early breast cancer: reappraisal of serum tumor markers</title><title>Surgery today (Tokyo, Japan)</title><addtitle>Surg Today</addtitle><description>The purpose of this study was to determine the most appropriate tests and procedures to detect disease progression effectively during the postoperative follow-up of patients with early breast cancer. We reevaluated our current surveillance protocol which involves the intensive follow-up of 643 patients with stage I disease. With the exception of one case of bone metastasis, all cases of recurrence (97%) were suspected from abnormal results detected during surveillance involving physical examination, serial determination of tumor markers, and chest roentgenography. Among 15 patients with asymptomatic distant metastasis, disease recurrence was suspected in 12 (80%) because of increased levels of serum tumor markers. No disease recurrence was detected by routine complete blood counts or automated chemistry studies alone. Our experience indicates that an effective follow-up regimen for patients with early breast cancer may include careful history-taking, physical examination, and the determination of serum tumor markers every 3-6 months for the first 3 years, then less frequently thereafter, and chest roentgenography every 6 months for 5 years, in addition to annual mammography. Serial determination of the tumor markers tumor polypeptide antigen, NCC-ST-439, and either carcinoembryonic antigen or carbohydrate antigen 15-3, seems to be of value for the selection of patients who should undergo radiologic exploration. The health benefits and cost-effectiveness of a follow-up focused on the measurement of serum tumor markers need to be evaluated in large prospective randomized trials.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers, Tumor - blood</subject><subject>Breast Neoplasms - blood</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Breast Neoplasms - surgery</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Recurrence, Local - diagnosis</subject><subject>Physical Examination</subject><subject>Postoperative Period</subject><subject>Predictive Value of Tests</subject><subject>Registries - statistics & numerical data</subject><subject>Sensitivity and Specificity</subject><subject>Time Factors</subject><issn>0941-1291</issn><issn>1436-2813</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpFkE1PwzAMhiMEYmNw5oZy4hbmNEmbckMTX9IkOMA5pJkrCu1SkpRp_55Om8TJsvW8lv0QcsnhhgMU86hKxQAypjnkTB2RKZciZ5nm4phMoZSc8azkE3IW49fISQ1wSiac64Jrzqfk49XH5HsMNjW_SGvftn7Dhp76mvbjDNcp0k2TPina0G5pFdDGRJ1dOwy3dOz6Ptgm2naXiBiGjqah84F2NnxjiOfkpLZtxItDnZH3h_u3xRNbvjw-L-6WzAmpE1Naq0pgXqrcFSAUSoGisKvcAfDxVQ01yMpW0qqiElCJAgqXr5SWYJ3UpZiR6_3ePvifAWMyXRMdtq1dox-iKbjUuRLZCM73oAs-xoC16UMzHrs1HMxOqtlJNaMss5Nq1Ji4Oqweqg5X__zBovgDRhRylQ</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Anan, Keisei</creator><creator>Mitsuyama, Shoshu</creator><creator>Tamae, Keiyoshi</creator><creator>Suehara, Nobuhiro</creator><creator>Nishihara, Kazuyoshi</creator><creator>Ogawa, Yoshiaki</creator><creator>Iwashita, Toshimitsu</creator><creator>Abe, Yuji</creator><creator>Ihara, Takaaki</creator><creator>Nakahara, Shosaku</creator><creator>Katsumoto, Fujio</creator><creator>Toyoshima, Satoshi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Postoperative follow-up of patients with early breast cancer: reappraisal of serum tumor markers</title><author>Anan, Keisei ; Mitsuyama, Shoshu ; Tamae, Keiyoshi ; Suehara, Nobuhiro ; Nishihara, Kazuyoshi ; Ogawa, Yoshiaki ; Iwashita, Toshimitsu ; Abe, Yuji ; Ihara, Takaaki ; Nakahara, Shosaku ; Katsumoto, Fujio ; Toyoshima, Satoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-5885b3e6956c7035e43e37ad6c00110080f04bab4a57b30b3707c6d5840ac4893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers, Tumor - blood</topic><topic>Breast Neoplasms - blood</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Breast Neoplasms - surgery</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Recurrence, Local - diagnosis</topic><topic>Physical Examination</topic><topic>Postoperative Period</topic><topic>Predictive Value of Tests</topic><topic>Registries - statistics & numerical data</topic><topic>Sensitivity and Specificity</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anan, Keisei</creatorcontrib><creatorcontrib>Mitsuyama, Shoshu</creatorcontrib><creatorcontrib>Tamae, Keiyoshi</creatorcontrib><creatorcontrib>Suehara, Nobuhiro</creatorcontrib><creatorcontrib>Nishihara, Kazuyoshi</creatorcontrib><creatorcontrib>Ogawa, Yoshiaki</creatorcontrib><creatorcontrib>Iwashita, Toshimitsu</creatorcontrib><creatorcontrib>Abe, Yuji</creatorcontrib><creatorcontrib>Ihara, Takaaki</creatorcontrib><creatorcontrib>Nakahara, Shosaku</creatorcontrib><creatorcontrib>Katsumoto, Fujio</creatorcontrib><creatorcontrib>Toyoshima, Satoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery today (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anan, Keisei</au><au>Mitsuyama, Shoshu</au><au>Tamae, Keiyoshi</au><au>Suehara, Nobuhiro</au><au>Nishihara, Kazuyoshi</au><au>Ogawa, Yoshiaki</au><au>Iwashita, Toshimitsu</au><au>Abe, Yuji</au><au>Ihara, Takaaki</au><au>Nakahara, Shosaku</au><au>Katsumoto, Fujio</au><au>Toyoshima, Satoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postoperative follow-up of patients with early breast cancer: reappraisal of serum tumor markers</atitle><jtitle>Surgery today (Tokyo, Japan)</jtitle><addtitle>Surg Today</addtitle><date>2002</date><risdate>2002</risdate><volume>32</volume><issue>1</issue><spage>13</spage><epage>18</epage><pages>13-18</pages><issn>0941-1291</issn><eissn>1436-2813</eissn><abstract>The purpose of this study was to determine the most appropriate tests and procedures to detect disease progression effectively during the postoperative follow-up of patients with early breast cancer. We reevaluated our current surveillance protocol which involves the intensive follow-up of 643 patients with stage I disease. With the exception of one case of bone metastasis, all cases of recurrence (97%) were suspected from abnormal results detected during surveillance involving physical examination, serial determination of tumor markers, and chest roentgenography. Among 15 patients with asymptomatic distant metastasis, disease recurrence was suspected in 12 (80%) because of increased levels of serum tumor markers. No disease recurrence was detected by routine complete blood counts or automated chemistry studies alone. Our experience indicates that an effective follow-up regimen for patients with early breast cancer may include careful history-taking, physical examination, and the determination of serum tumor markers every 3-6 months for the first 3 years, then less frequently thereafter, and chest roentgenography every 6 months for 5 years, in addition to annual mammography. Serial determination of the tumor markers tumor polypeptide antigen, NCC-ST-439, and either carcinoembryonic antigen or carbohydrate antigen 15-3, seems to be of value for the selection of patients who should undergo radiologic exploration. The health benefits and cost-effectiveness of a follow-up focused on the measurement of serum tumor markers need to be evaluated in large prospective randomized trials.</abstract><cop>Japan</cop><pmid>11871811</pmid><doi>10.1007/s595-002-8106-5</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0941-1291 |
ispartof | Surgery today (Tokyo, Japan), 2002, Vol.32 (1), p.13-18 |
issn | 0941-1291 1436-2813 |
language | eng |
recordid | cdi_proquest_miscellaneous_71486532 |
source | Springer Nature |
subjects | Adult Aged Biomarkers, Tumor - blood Breast Neoplasms - blood Breast Neoplasms - epidemiology Breast Neoplasms - surgery Disease Progression Female Follow-Up Studies Humans Middle Aged Neoplasm Metastasis Neoplasm Recurrence, Local - diagnosis Physical Examination Postoperative Period Predictive Value of Tests Registries - statistics & numerical data Sensitivity and Specificity Time Factors |
title | Postoperative follow-up of patients with early breast cancer: reappraisal of serum tumor markers |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A30%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postoperative%20follow-up%20of%20patients%20with%20early%20breast%20cancer:%20reappraisal%20of%20serum%20tumor%20markers&rft.jtitle=Surgery%20today%20(Tokyo,%20Japan)&rft.au=Anan,%20Keisei&rft.date=2002&rft.volume=32&rft.issue=1&rft.spage=13&rft.epage=18&rft.pages=13-18&rft.issn=0941-1291&rft.eissn=1436-2813&rft_id=info:doi/10.1007/s595-002-8106-5&rft_dat=%3Cproquest_cross%3E71486532%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-5885b3e6956c7035e43e37ad6c00110080f04bab4a57b30b3707c6d5840ac4893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71486532&rft_id=info:pmid/11871811&rfr_iscdi=true |